Innovating Works

PHAGOVET

Financiado
A cost effective solution for controlling Salmonella and Escherichia coli in pou...
A cost effective solution for controlling Salmonella and Escherichia coli in poultry production The Phagovet project is devised to satisfy market demand for a more secure and reliable solution to control Salmonella and E. coli infections in poultry farms. With more than 40,000 poultry farms, the European Union (EU-28) is the... The Phagovet project is devised to satisfy market demand for a more secure and reliable solution to control Salmonella and E. coli infections in poultry farms. With more than 40,000 poultry farms, the European Union (EU-28) is the forth world´s top producers in poultry meat (13.1 million tons, 2014) and the second largest egg producer (>11 million tons, 2014). The European poultry industry employs 302,000 staff across Europe and has an annual turnover of €30 B, being then of significant economic importance. To date, avian colibacillosis and salmonellosis are considered the main bacterial infections in the poultry sector having an important economic impact worldwide. Furthermore, EFSA estimated overall economic burden of human salmonellosis at €3B/year. Finally, the overuse of antibiotic in farming has caused a rise in antimicrobial resistance 700,000 people die annually from drug resistant infections and it is estimated that this number will rise to 10 million by 2050. In response to the unmet need, Phagovet proposes a cost-effective alternative to antibiotics against Salmonella and E. coli. Phagovet consists of a biocide and two technological food additive products based on selected bacteriophages able to kill the target bacteria. Phagovet will be the first phage-based solution to naturally and effectively control both bacteria in poultry production while avoiding side effects and residues associated to antibiotic use. It will reduce Sallmonella infections by 20% and reduce the use of antibiotics on E. coli by 50%. Thus, Phagovet provides a promising effective control measure for a concerning problem for poultry farmers and for human health. The successful market launch of Phagovet will enable members of the Consortium to consolidate their position in the Animal Health, Food Safety and Environmental Control markets and commercialize the product worldwide, reaching €17.76M profit at the end of 2026. ver más
31/10/2022
3M€
Duración del proyecto: 49 meses Fecha Inicio: 2018-09-13
Fecha Fin: 2022-10-31

Línea de financiación: concedida

El organismo H2020 notifico la concesión del proyecto el día 2022-10-31
Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:
Presupuesto El presupuesto total del proyecto asciende a 3M€
Líder del proyecto
ALS LIFE SCIENCES PORTUAL S.A No se ha especificado una descripción o un objeto social para esta compañía.
Perfil tecnológico TRL 4-5